Literature DB >> 4004196

Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

J F Reinhardt, W L George.   

Abstract

The in vitro antimicrobial susceptibilities of fecal isolates of Aeromonas caviae, Aeromonas hydrophila, Aeromonas sobria, and Plesiomonas shigelloides were tested by agar dilution. This in vitro study suggested that ciprofloxacin, enoxacin, norfloxacin, tetracycline, and trimethoprim-sulfamethoxazole might be effective oral agents for treatment of diarrhea involving Aeromonas spp. or P. shigelloides.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4004196      PMCID： PMC180112          DOI： 10.1128/AAC.27.4.643

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.

Authors:  K Montgomery; L Raymundo; W L Drew
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

2.  The genus aeromonas in human bacteriology; report of 30 cases and review of the literature.

Authors:  A Von Graevenitz; A H Mensch
Journal:  N Engl J Med       Date:  1968-02-01       Impact factor: 91.245

3.  Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers.

Authors:  R D Cofsky; L duBouchet; S H Landesman
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Neonatal septicemia and meningitis due to Plesiomonas shigelloides.

Authors:  A Pathak; J R Custer; J Levy
Journal:  Pediatrics       Date:  1983-03       Impact factor: 7.124

5.  In-vitro susceptibility of Aeromonas app. to antimicrobial agents.

Authors:  C J Richardson; J O Robinson; L B Wagener; V Burke
Journal:  J Antimicrob Chemother       Date:  1982-04       Impact factor: 5.790

6.  Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum.

Authors:  J M Janda; M Reitano; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

7.  Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors:  L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.

Authors:  J R Carlson; S A Thornton; H L DuPont; A H West; J J Mathewson
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

Review 9.  Aeromonas hydrophila and Plesiomonas shigelloides as causes of intestinal infections.

Authors:  S D Holmberg; J J Farmer
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
  9 in total
  19 in total

1.  Antimicrobial susceptibility of Plesiomonas shigelloides from patients with diarrhea.

Authors:  K C Kain; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations.

Authors:  R B Clark; P D Lister; L Arneson-Rotert; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  Activity of newer antimicrobial agents against Aeromonas hydrophila.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 4.  [Enoxacin: spectrum and activity of its antibacterial effect].

Authors:  A Bauernfeind; H Flamm; H Grimm; H Hahn; F Kayser; W Opferkuch; J Potel; R Malottke; H G Sonntag; W H Traub
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 5.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

6.  Comparative in vitro activities of selected antimicrobial agents against Edwardsiella tarda.

Authors:  J F Reinhardt; S Fowlston; J Jones; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

7.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

8.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 9.  Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; D M Richards
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

Review 10.  Gastroenteritis, sepsis, and osteomyelitis caused by Plesiomonas shigelloides in an immunocompetent host: case report and review of the literature.

Authors:  C W Ingram; A J Morrison; R E Levitz
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.